Healthcare Access

Pharmacia allows generics of low-demand AIDS drug for poor nations

Published in AIDS Weekly, February 10th, 2003

Pharmacia Corp. has announced it would allow generic drug companies to manufacture cheap copies of its AIDS drug to sell in poor countries - a novel approach aimed at breaking the logjam over access to lifesaving medicines.

Pharmacia said it will work with the International Dispensary Association (IDA) in Amsterdam to provide licenses and technological skills to generic companies to make its drug delavirdine, an antiretroviral sold under the trade name Rescriptor.

AIDS activists praised the idea of using a nonprofit agency as an intermediary - even if the drug on offer is not in great demand. But they stressed that without billions more in aid from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-02-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry